Site-Specific Modification of Virus-Like Particles for Exogenous Tumor Antigen Display and Minimizing Preexisting Immunity.
Cheng K, Ma N, Liang J, Ma X, Feng Q, Liu G, Xu C, Tang M, Zhang L, Gao X, Xu J, Wang C, Zhu F, Wang X, Li X, Zhao X, Nie G.
Cheng K, et al. Among authors: ma n, ma x.
Small. 2023 Jun;19(23):e2300125. doi: 10.1002/smll.202300125. Epub 2023 Mar 6.
Small. 2023.
PMID: 36879481